← All candidates
Three insider buys in the last year — $494.7K in all.
32 filings on record.
MYGNMYRIAD GENETICS INC
NasdaqGS · Healthcare · $371.12M
$3.88
+2.37% · Sep 15
Three insider buys in the last year — $494.7K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 3 buys
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$371.12M
Float
87.1M
91% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
0.7
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Phanstiel S. Louise
Bought $242.1K on Feb 26 — 50,407 sh @ $4.80, held direct, 22% of their stake.
1 of 2 positions beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
24 more transactions on Pro →Context
Wall St
$6.25 avg target
+61.1% vs today · 8 analysts · consensus Hold
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$0.09 act−$0.02
Q4 '25$0.04 act+$0.06
Q3 '25$0.00 act+$0.01
Q2 '25$0.05 act+$0.06
Coverage
Should You Add Myriad Genetics Stock to Your Portfolio Right Now?Zacks · 06-09Myriad (MYGN) Up 7.1% Since Last Earnings Report: Can It Continue?Zacks · 06-04Myriad Genetics' Upcoming Prolaris + AI Test Debut May Lift Its StockZacks · 05-28Is MYGN Stock a Buy at 0.4x Sales? What Investors Should WeighZacks · 05-28
The file stays open
32 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice